This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Non-melanomatous Skin Cancer, Pancreatic Cancer, Small Intestine Cancer or Testicular Germ Cell Tumor
and you are
-
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is evaluating a tumor marker for testicular cancer, skin cancer, small intestine cancer, and pancreatic cancer.

Provided treatments

  • Genetic: in situ hybridization
  • Genetic: protein expression analysis
  • Other: immunologic technique
Tris trial is registered with FDA with number: NCT00899132. The sponsor of the trial is Case Comprehensive Cancer Center and it is looking for 180 volunteers for the current phase.
Official trial title:
The Role of TAB3 Protein in Tumorigenesis